Results 281 to 290 of about 3,094,120 (388)

Longitudinal Study of Treatment Variability for Parkinson's Disease across Specialized Centers

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Real‐world evidence on treatment practices in Parkinson's disease (PD) has been limited due to the difficulty in collecting comprehensive and generalizable clinical data. Objectives We sought to identify treatment patterns and test how treatment changed in response to (1) falling, (2) worsening disease, and (3) worsening quality of ...
Nabila Dahodwala   +11 more
wiley   +1 more source

Subcutaneous Apomorphine Infusion Initiation Is Associated with Impulse Control Disorder Attenuation in Advanced Parkinson's Disease Patients: Insights from the French NS‐Park Cohort

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Impulse control disorders (ICD) are common non‐motor complications in Parkinson's disease (PD), particularly in patients receiving oral dopamine agonists (DA). Continuous subcutaneous apomorphine infusion (CSAI) is a device‐aided therapy for advanced PD, but its effects on ICD remain underexplored in real‐world settings.
Clément Desjardins   +249 more
wiley   +1 more source

Do psychotic symptoms predict future psychotic disorders in adolescent psychiatry inpatients? A 17-year cohort study. [PDF]

open access: yesPsychol Med
Kieseppä V   +10 more
europepmc   +1 more source

Interpersonal Psychotherapy for the Treatment of Depression in Parkinson's Disease: Results of a Randomized Controlled Trial

open access: yesMovement Disorders, EarlyView.
Abstract Background Depression is a common nonmotor complication in Parkinson's disease (PD). However, few studies have evaluated the efficacy of first‐line psychological therapies for depression in this patient population. Objectives This randomized controlled trial evaluated the efficacy of interpersonal psychotherapy (IPT), an empirically validated ...
Diana Koszycki   +5 more
wiley   +1 more source

Transdiagnostic modeling of clinician-rated symptoms in affective and nonaffective psychotic disorders. [PDF]

open access: yesJ Psychopathol Clin Sci
Chung Y   +5 more
europepmc   +1 more source

Evaluation of Induced Pluripotent Stem Cell‐Derived Dopaminergic Neurons from Siblings with Gaucher Disease Discordant for Parkinsonism

open access: yesMovement Disorders, EarlyView.
Abstract Background In Gaucher disease (GD), glucocerebrosidase (GCase) deficiency results from biallelic pathogenic GBA1 variants. While GBA1 variants are a major risk factor for Parkinson's disease (PD), most patients with GD never develop parkinsonism.
Ellen Hertz   +12 more
wiley   +1 more source

Subcutaneous Foslevodopa as Novel Rescue Therapy for Akinetic Crisis in Parkinson's Disease: A Case Report

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Bendix Labeit   +3 more
wiley   +1 more source

Protective Effects of Genetic Proxies of Cognitive Reserve in Parkinson's Disease: A Longitudinal Multi‐Cohort Study

open access: yesMovement Disorders, EarlyView.
ABSTRACT Background Resilience factors are crucial in the progression of neurodegenerative diseases. However, it remains unclear whether a genetic predisposition to cognitive reserve influences clinical heterogeneity in the prognosis of Parkinson's disease (PD).
Young Eun Huh   +5 more
wiley   +1 more source

Pragmatic language production in mood and psychotic disorders a systematic review and meta-analysis

open access: yes
Meister F   +10 more
europepmc   +1 more source

Sensitivity of the clinical high-risk and familial high-risk approaches for psychotic disorders - a systematic review and meta-analysis. [PDF]

open access: yesPsychol Med
Talukder A   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy